A double-blinded, placebo-controlled, cross-over pilot trial in healthy men to study the effects of Angelica gigas herbal supplement on prostate cancer–relevant inflammatory cytokines.

Authors

null

Anne-Laure Strong

Penn State College of Medicine, Hershey, PA

Anne-Laure Strong , Deepkamal N. Karelia , Todd D. Schell , Diane Hershock , Tongyao Fan , Dongxiao Sun , Junjia Zhu , Elizabeth Proctor , Cheng Jiang , Monika Joshi , Junxuan Lu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Clinical Trial Registration Number

NCT03630328

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 170)

DOI

10.1200/JCO.2024.42.4_suppl.170

Abstract #

170

Poster Bd #

G20

Abstract Disclosures

Similar Posters

First Author: Carlos A. Gomez-Roca

First Author: Monika Joshi

First Author: Karan Jatwani

First Author: Joan Miguel Romero